Jinghui Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jinghui Zhang has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Kenneth H. Buetow
Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
4 shared publicationsRichard P. Finney
Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
3 shared publicationsGang Wu
St. Jude Children’s Research Hospital, Memphis, TN, USA
2 shared publications- Jeffery P. Struewing
Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2 shared publications - Kenneth H. Buetow
Laboratory of Population Genetics, National Institutes of Health, Bethesda, Maryland, United States of America
2 shared publications Michael Edmonson
Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
2 shared publications
Latest Publications
- 22 June 2018
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 20 (suppl_2) , i63
DIPG-68. ONCOGENIC MECHANISMS OF H3.3 K27M IN A SPONTANEOUS DIPG MOUSE MODEL
Diffuse intrinsic pontine gliomas (DIPG) are deadly childhood brainstem tumors that comprise approximately half of all pediatric high-grade gliomas (HGG). Recurrent, clonal somatic mutations in histone H3 are a molecular hallmark that distinguish genetic mechanisms underlying pediatric and adult HGG, and indicate a strong link between epigenetic dysfunction and pediatric brain tumorigenesis. H3K27M mutations found in nearly 80 percent of DIPGs and over half of non-brainstem HGGs occurring in thalamus or other midline structures, induce a dominant loss of genome-wide H3K27me3. To study this mutation in the developing mammalian brain and investigate how it contributes to gliomagenesis, we generated conditionally activated, epitope-tagged knock-in mice to express K27M or non-mutated H3.3 proteins from the endogenous H3f3a locus. Untransformed embryonic neural precursor cells expressing H3.3K27M demonstrated H3K27me3 loss and a significant growth advantage in vitro with brain region-specific, stage-dependent expression and epigenetic signatures. DIPGs frequently harbor genetic alterations in TP53 and PDGFRA in addition to H3.3K27M, and mice with induced brain-specific Trp53 deletion plus mutated PDGFRAV544ins expression developed spontaneous HGG in vivo. Induction of H3.3K27M significantly accelerated PDGFRAV544ins;Trp53 knockout HGG formation involving the brainstem. Importantly, non-mutated H3.3 epitope-tagged protein did not affect tumor burden or latency. H3.3K27M tumors recapitulate characteristics observed in human DIPG including histopathological features, strong nuclear K27M expression and robust loss of H3K27me3 throughout the tumors. Using RNA-seq and ChIP-seq, we relate the genetic, epigenetic and transcriptional landscapes of these models to primary pediatric DIPG to help identify their developmental origins and oncogenic mechanisms downstream of histone H3.3K27M.
- 22 June 2018
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 20 (suppl_2) , i63
DIPG-68. ONCOGENIC MECHANISMS OF H3.3 K27M IN A SPONTANEOUS DIPG MOUSE MODEL
Diffuse intrinsic pontine gliomas (DIPG) are deadly childhood brainstem tumors that comprise approximately half of all pediatric high-grade gliomas (HGG). Recurrent, clonal somatic mutations in histone H3 are a molecular hallmark that distinguish genetic mechanisms underlying pediatric and adult HGG, and indicate a strong link between epigenetic dysfunction and pediatric brain tumorigenesis. H3K27M mutations found in nearly 80 percent of DIPGs and over half of non-brainstem HGGs occurring in thalamus or other midline structures, induce a dominant loss of genome-wide H3K27me3. To study this mutation in the developing mammalian brain and investigate how it contributes to gliomagenesis, we generated conditionally activated, epitope-tagged knock-in mice to express K27M or non-mutated H3.3 proteins from the endogenous H3f3a locus. Untransformed embryonic neural precursor cells expressing H3.3K27M demonstrated H3K27me3 loss and a significant growth advantage in vitro with brain region-specific, stage-dependent expression and epigenetic signatures. DIPGs frequently harbor genetic alterations in TP53 and PDGFRA in addition to H3.3K27M, and mice with induced brain-specific Trp53 deletion plus mutated PDGFRAV544ins expression developed spontaneous HGG in vivo. Induction of H3.3K27M significantly accelerated PDGFRAV544ins;Trp53 knockout HGG formation involving the brainstem. Importantly, non-mutated H3.3 epitope-tagged protein did not affect tumor burden or latency. H3.3K27M tumors recapitulate characteristics observed in human DIPG including histopathological features, strong nuclear K27M expression and robust loss of H3K27me3 throughout the tumors. Using RNA-seq and ChIP-seq, we relate the genetic, epigenetic and transcriptional landscapes of these models to primary pediatric DIPG to help identify their developmental origins and oncogenic mechanisms downstream of histone H3.3K27M.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , 10502
A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS).
10502 Background: CCS are at increased risk of therapy-related PM but contribution of genetic factors is unknown. Methods: Using Affymetrix 6.0 SNP array, treatment exposures [cumulative alkylating agents (AA), ovarian radiotherapy (RT) dose] and clinically-assessed PM status (menopause < 40 years), a genome-wide association analysis was conducted using logistic regression in SJLIFE. A cluster of most statistically significant SNPs on chr4 was further examined, stratifying by ovarian RT and AA. Replication was performed using self-reported PM in CCSS. Results: PM was diagnosed in 30 of 805 SJLIFE female survivors. A loci of 13 SNPs in 4 linkage disequilibrium blocks (mean r2 = 0.51) in the upstream regulatory region of Neuropeptide Receptor 2 ( NPY2R) was identified with a minimum p-value of 3.3x10-7 (all -5). ENCODE gene expression, motifs, and chromatin remodeling data suggest these SNPs alter transcription factor binding sites, potentially disrupting neuroendocrine events necessary for ovulation. Among CCS exposed to ovarian RT, homozygous carriers of a risk profile (RP) defined by 4 of the 13 SNPs, found in over half of the survivors with clinically-diagnosed PM and 1 in 7 in the general population, significantly increased PM risk (odds ratio (OR) 25.8, p=5.4x10-5) (Table). This finding was replicated using self-reported PM status of 1644 survivors in CCSS (OR 4.2, p=4.6x10-4). Prediction of clinically-diagnosed PM (in the SJLIFE discovery cohort) improved by adding the RP to the model with age and treatment (area under ROC curve 0.84 vs. 0.93, p=0.011). Conclusions: The common RP is associated with PM risk in pediatric cancer survivors and may have potential for clinical application. [Table: see text]
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , 10502
A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS).
10502 Background: CCS are at increased risk of therapy-related PM but contribution of genetic factors is unknown. Methods: Using Affymetrix 6.0 SNP array, treatment exposures [cumulative alkylating agents (AA), ovarian radiotherapy (RT) dose] and clinically-assessed PM status (menopause < 40 years), a genome-wide association analysis was conducted using logistic regression in SJLIFE. A cluster of most statistically significant SNPs on chr4 was further examined, stratifying by ovarian RT and AA. Replication was performed using self-reported PM in CCSS. Results: PM was diagnosed in 30 of 805 SJLIFE female survivors. A loci of 13 SNPs in 4 linkage disequilibrium blocks (mean r2 = 0.51) in the upstream regulatory region of Neuropeptide Receptor 2 ( NPY2R) was identified with a minimum p-value of 3.3x10-7 (all -5). ENCODE gene expression, motifs, and chromatin remodeling data suggest these SNPs alter transcription factor binding sites, potentially disrupting neuroendocrine events necessary for ovulation. Among CCS exposed to ovarian RT, homozygous carriers of a risk profile (RP) defined by 4 of the 13 SNPs, found in over half of the survivors with clinically-diagnosed PM and 1 in 7 in the general population, significantly increased PM risk (odds ratio (OR) 25.8, p=5.4x10-5) (Table). This finding was replicated using self-reported PM status of 1644 survivors in CCSS (OR 4.2, p=4.6x10-4). Prediction of clinically-diagnosed PM (in the SJLIFE discovery cohort) improved by adding the RP to the model with age and treatment (area under ROC curve 0.84 vs. 0.93, p=0.011). Conclusions: The common RP is associated with PM risk in pediatric cancer survivors and may have potential for clinical application. [Table: see text]
- 19 March 2014
- Vol. 11 (1) , 1-12
Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma.
We report on next-generation transcriptome sequencing results of three human hepatocellular carcinoma tumor/tumor-adjacent pairs. This analysis robustly examined ∼12,000 genes for both expression differences and molecular alterations. We observed 4,513 and 1,182 genes demonstrating 2-fold or greater increase or decrease in expression relative to their normal, respectively. Network analysis of expression data identified the Aurora B signaling, FOXM1 transcription factor network and Wnt signaling pathways pairs being altered in HCC. We validated as differential gene expression findings in a large data set containing of 434 liver normal/tumor sample pairs. In addition to known driver mutations in TP53 and CTNNB1, our mutation analysis identified non-synonymous mutations in genes implicated in metabolic diseases, i.e. diabetes and obesity: IRS1, HMGCS1, ATP8B1, PRMT6 and CLU, suggesting a common molecular etiology for HCC of alternative pathogenic origin.
- 19 March 2014
- Vol. 11 (1) , 1-12
Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma.
We report on next-generation transcriptome sequencing results of three human hepatocellular carcinoma tumor/tumor-adjacent pairs. This analysis robustly examined ∼12,000 genes for both expression differences and molecular alterations. We observed 4,513 and 1,182 genes demonstrating 2-fold or greater increase or decrease in expression relative to their normal, respectively. Network analysis of expression data identified the Aurora B signaling, FOXM1 transcription factor network and Wnt signaling pathways pairs being altered in HCC. We validated as differential gene expression findings in a large data set containing of 434 liver normal/tumor sample pairs. In addition to known driver mutations in TP53 and CTNNB1, our mutation analysis identified non-synonymous mutations in genes implicated in metabolic diseases, i.e. diabetes and obesity: IRS1, HMGCS1, ATP8B1, PRMT6 and CLU, suggesting a common molecular etiology for HCC of alternative pathogenic origin.
- Open Access
- 4 October 2007
- Published by Springer Nature in BMC Genomic Data
- Vol. 8 (1) , 68
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies
Background: We studied linkage disequilibrium (LD) patterns at the BRCA1 locus, a susceptibility gene for breast and ovarian cancer, using a dense set of 114 single nucleotide polymorphisms in 5 population groups. We focused on Ashkenazi Jews in whom there are known founder mutations, to address the question of whether we would have been able to identify the 185delAG mutation in a case-control association study (should one have been done) using anonymous genetic markers. This mutation is present in approximately 1% of the general Ashkenazi population and 4% of Ashkenazi breast cancer cases. We evaluated LD using pairwise and haplotype-based methods, and assessed correlation of SNPs with the founder mutations using Pearson's correlation coefficient. Results: BRCA1 is characterized by very high linkage disequilibrium in all populations spanning several hundred kilobases. Overall, haplotype blocks and pair-wise LD bins were highly correlated, with lower LD in African versus non-African populations. The 185delAG and 5382insC founder mutations occur on the two most common haplotypes among Ashkenazim. Because these mutations are rare, even though they are in strong LD with many other SNPs in the region as measured by D-prime, there were no strong associations when assessed by Pearson's correlation coefficient, r (maximum of 0.04 for the 185delAG). Conclusion: Since the required sample size is related to the inverse of r, this suggests that it would have been difficult to map BRCA1 in an Ashkenazi case-unrelated control association study using anonymous markers that were linked to the founder mutations.
- 4 October 2007
- Published by Springer Nature in BMC Genomic Data
- Vol. 8 (1) , 68
Open AccessThe BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies
Background: We studied linkage disequilibrium (LD) patterns at the BRCA1 locus, a susceptibility gene for breast and ovarian cancer, using a dense set of 114 single nucleotide polymorphisms in 5 population groups. We focused on Ashkenazi Jews in whom there are known founder mutations, to address the question of whether we would have been able to identify the 185delAG mutation in a case-control association study (should one have been done) using anonymous genetic markers. This mutation is present in approximately 1% of the general Ashkenazi population and 4% of Ashkenazi breast cancer cases. We evaluated LD using pairwise and haplotype-based methods, and assessed correlation of SNPs with the founder mutations using Pearson's correlation coefficient. Results: BRCA1 is characterized by very high linkage disequilibrium in all populations spanning several hundred kilobases. Overall, haplotype blocks and pair-wise LD bins were highly correlated, with lower LD in African versus non-African populations. The 185delAG and 5382insC founder mutations occur on the two most common haplotypes among Ashkenazim. Because these mutations are rare, even though they are in strong LD with many other SNPs in the region as measured by D-prime, there were no strong associations when assessed by Pearson's correlation coefficient, r (maximum of 0.04 for the 185delAG). Conclusion: Since the required sample size is related to the inverse of r, this suggests that it would have been difficult to map BRCA1 in an Ashkenazi case-unrelated control association study using anonymous markers that were linked to the founder mutations.
- 24 May 2007
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 17 (7) , 1111-1117
Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB)
Systematic investigations of genetic changes in tumors are expected to lead to greatly improved understanding of cancer etiology. To meet the analytical challenges presented by such studies, we developed the Cancer Genome WorkBench (http://cgwb.nci.nih.gov), the first computational platform to integrate clinical tumor mutation profiles with the reference human genome. A novel heuristic algorithm, IndelDetector, was developed to automatically identify insertion/deletion (indel) polymorphisms as well as indel somatic mutations with high sensitivity and accuracy. It was incorporated into an automated pipeline that detects genetic alterations and annotates their effects on protein coding and 3D structure. The ability of the system to facilitate identifying genetic alterations is illustrated in three projects with publicly accessible data. Mutagenesis in tumor DNA replication leading to complex genetic changes in the EGFR kinase domain is suggested by a novel deletion–insertion combination observed in paired tumor–normal lung cancer resequencing data. Automated analysis of 152 genes resequenced by the SeattleSNPs group was able to identify 91% of the 1251 indel polymorphisms discovered by SeattleSNPs. In addition, our system discovered 518 novel indels in this data set, 451 of which were found to be valid by manual inspection of sequence traces. Our experience demonstrates that CGWB not only greatly improves the productivity and the accuracy of mutation identification, but also, through its data integration and visualization capabilities, facilitates identification of underlying genetic etiology.
- 24 May 2007
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 17 (7) , 1111-1117
Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB)
Systematic investigations of genetic changes in tumors are expected to lead to greatly improved understanding of cancer etiology. To meet the analytical challenges presented by such studies, we developed the Cancer Genome WorkBench (http://cgwb.nci.nih.gov), the first computational platform to integrate clinical tumor mutation profiles with the reference human genome. A novel heuristic algorithm, IndelDetector, was developed to automatically identify insertion/deletion (indel) polymorphisms as well as indel somatic mutations with high sensitivity and accuracy. It was incorporated into an automated pipeline that detects genetic alterations and annotates their effects on protein coding and 3D structure. The ability of the system to facilitate identifying genetic alterations is illustrated in three projects with publicly accessible data. Mutagenesis in tumor DNA replication leading to complex genetic changes in the EGFR kinase domain is suggested by a novel deletion–insertion combination observed in paired tumor–normal lung cancer resequencing data. Automated analysis of 152 genes resequenced by the SeattleSNPs group was able to identify 91% of the 1251 indel polymorphisms discovered by SeattleSNPs. In addition, our system discovered 518 novel indels in this data set, 451 of which were found to be valid by manual inspection of sequence traces. Our experience demonstrates that CGWB not only greatly improves the productivity and the accuracy of mutation identification, but also, through its data integration and visualization capabilities, facilitates identification of underlying genetic etiology.
- Open Access
- 14 March 2006
- Published by Springer Nature in BMC Bioinformatics
- Vol. 7 (1) , 135
Gene functional similarity search tool (GFSST)
Background: With the completion of the genome sequences of human, mouse, and other species and the advent of high throughput functional genomic research technologies such as biomicroarray chips, more and more genes and their products have been discovered and their functions have begun to be understood. Increasing amounts of data about genes, gene products and their functions have been stored in databases. To facilitate selection of candidate genes for gene-disease research, genetic association studies, biomarker and drug target selection, and animal models of human diseases, it is essential to have search engines that can retrieve genes by their functions from proteome databases. In recent years, the development of Gene Ontology (GO) has established structured, controlled vocabularies describing gene functions, which makes it possible to develop novel tools to search genes by functional similarity. Results: By using a statistical model to measure the functional similarity of genes based on the Gene Ontology directed acyclic graph, we developed a novel Gene Functional Similarity Search Tool (GFSST) to identify genes with related functions from annotated proteome databases. This search engine lets users design their search targets by gene functions. Conclusion: An implementation of GFSST which works on the UniProt (Universal Protein Resource) for the human and mouse proteomes is available at GFSST Web Server. GFSST provides functions not only for similar gene retrieval but also for gene search by one or more GO terms. This represents a powerful new approach for selecting similar genes and gene products from proteome databases according to their functions.
- 14 March 2006
- Published by Springer Nature in BMC Bioinformatics
- Vol. 7 (1) , 135
Open AccessGene functional similarity search tool (GFSST)
Background: With the completion of the genome sequences of human, mouse, and other species and the advent of high throughput functional genomic research technologies such as biomicroarray chips, more and more genes and their products have been discovered and their functions have begun to be understood. Increasing amounts of data about genes, gene products and their functions have been stored in databases. To facilitate selection of candidate genes for gene-disease research, genetic association studies, biomarker and drug target selection, and animal models of human diseases, it is essential to have search engines that can retrieve genes by their functions from proteome databases. In recent years, the development of Gene Ontology (GO) has established structured, controlled vocabularies describing gene functions, which makes it possible to develop novel tools to search genes by functional similarity. Results: By using a statistical model to measure the functional similarity of genes based on the Gene Ontology directed acyclic graph, we developed a novel Gene Functional Similarity Search Tool (GFSST) to identify genes with related functions from annotated proteome databases. This search engine lets users design their search targets by gene functions. Conclusion: An implementation of GFSST which works on the UniProt (Universal Protein Resource) for the human and mouse proteomes is available at GFSST Web Server. GFSST provides functions not only for similar gene retrieval but also for gene search by one or more GO terms. This represents a powerful new approach for selecting similar genes and gene products from proteome databases according to their functions.
- Open Access
- 28 October 2005
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 1 (5) , e53
SNPdetector: A Software Tool for Sensitive and Accurate SNP Detection
Identification of single nucleotide polymorphisms (SNPs) and mutations is important for the discovery of genetic predisposition to complex diseases. PCR resequencing is the method of choice for de novo SNP discovery. However, manual curation of putative SNPs has been a major bottleneck in the application of this method to high-throughput screening. Therefore it is critical to develop a more sensitive and accurate computational method for automated SNP detection. We developed a software tool, SNPdetector, for automated identification of SNPs and mutations in fluorescence-based resequencing reads. SNPdetector was designed to model the process of human visual inspection and has a very low false positive and false negative rate. We demonstrate the superior performance of SNPdetector in SNP and mutation analysis by comparing its results with those derived by human inspection, PolyPhred (a popular SNP detection tool), and independent genotype assays in three large-scale investigations. The first study identified and validated inter- and intra-subspecies variations in 4,650 traces of 25 inbred mouse strains that belong to either the Mus musculus species or the M. spretus species. Unexpected heterozgyosity in CAST/Ei strain was observed in two out of 1,167 mouse SNPs. The second study identified 11,241 candidate SNPs in five ENCODE regions of the human genome covering 2.5 Mb of genomic sequence. Approximately 50% of the candidate SNPs were selected for experimental genotyping; the validation rate exceeded 95%. The third study detected ENU-induced mutations (at 0.04% allele frequency) in 64,896 traces of 1,236 zebra fish. Our analysis of three large and diverse test datasets demonstrated that SNPdetector is an effective tool for genome-scale research and for large-sample clinical studies. SNPdetector runs on Unix/Linux platform and is available publicly (http://lpg.nci.nih.gov). Single nucleotide polymorphisms (SNPs) are an abundant and important class of heritable genetic variations, and many of them contribute to genetic diseases. Accurate and automated detection of SNPs as heterozygous alleles in fluorescence-based sequencing traces from diploid DNA samples is challenging because of the low signal-to-noise ratio in the data, and because of sequencing artifacts associated with the various DNA sequencing chemistries. The authors of this publication have developed a new computer program, SNPdetector, that improves upon existing software tools. The main design principle of SNPdetector was to model the process of human visual inspection of experienced analysts. The new tool is able to cut down significantly on both false positive and false negative discovery rates. Good performance can be achieved, without the need for retraining, in substantially different datasets such as SNP discovery in human resequencing data, mutation discovery in zebra fish candidate genes, and discovery of inter- and intra-subspecies variations in inbred mouse strains. The results demonstrate that this software tool is suitable for the automation of SNP discovery in diploid sequencing traces, and permits a substantial reduction of costly and laborious visual data analysis.
- 28 October 2005
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 1 (5) , e53
Open AccessSNPdetector: A Software Tool for Sensitive and Accurate SNP Detection
Identification of single nucleotide polymorphisms (SNPs) and mutations is important for the discovery of genetic predisposition to complex diseases. PCR resequencing is the method of choice for de novo SNP discovery. However, manual curation of putative SNPs has been a major bottleneck in the application of this method to high-throughput screening. Therefore it is critical to develop a more sensitive and accurate computational method for automated SNP detection. We developed a software tool, SNPdetector, for automated identification of SNPs and mutations in fluorescence-based resequencing reads. SNPdetector was designed to model the process of human visual inspection and has a very low false positive and false negative rate. We demonstrate the superior performance of SNPdetector in SNP and mutation analysis by comparing its results with those derived by human inspection, PolyPhred (a popular SNP detection tool), and independent genotype assays in three large-scale investigations. The first study identified and validated inter- and intra-subspecies variations in 4,650 traces of 25 inbred mouse strains that belong to either the Mus musculus species or the M. spretus species. Unexpected heterozgyosity in CAST/Ei strain was observed in two out of 1,167 mouse SNPs. The second study identified 11,241 candidate SNPs in five ENCODE regions of the human genome covering 2.5 Mb of genomic sequence. Approximately 50% of the candidate SNPs were selected for experimental genotyping; the validation rate exceeded 95%. The third study detected ENU-induced mutations (at 0.04% allele frequency) in 64,896 traces of 1,236 zebra fish. Our analysis of three large and diverse test datasets demonstrated that SNPdetector is an effective tool for genome-scale research and for large-sample clinical studies. SNPdetector runs on Unix/Linux platform and is available publicly (http://lpg.nci.nih.gov). Single nucleotide polymorphisms (SNPs) are an abundant and important class of heritable genetic variations, and many of them contribute to genetic diseases. Accurate and automated detection of SNPs as heterozygous alleles in fluorescence-based sequencing traces from diploid DNA samples is challenging because of the low signal-to-noise ratio in the data, and because of sequencing artifacts associated with the various DNA sequencing chemistries. The authors of this publication have developed a new computer program, SNPdetector, that improves upon existing software tools. The main design principle of SNPdetector was to model the process of human visual inspection of experienced analysts. The new tool is able to cut down significantly on both false positive and false negative discovery rates. Good performance can be achieved, without the need for retraining, in substantially different datasets such as SNP discovery in human resequencing data, mutation discovery in zebra fish candidate genes, and discovery of inter- and intra-subspecies variations in inbred mouse strains. The results demonstrate that this software tool is suitable for the automation of SNP discovery in diploid sequencing traces, and permits a substantial reduction of costly and laborious visual data analysis.
- Open Access
- 1 February 2005
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 15 (2) , 241-249
A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns
Understanding of the structure and the origin of genetic variation patterns in the laboratory inbred mouse provides insight into the utility of the mouse model for studying human complex diseases and strategies for disease gene mapping. In order to address this issue, we have constructed a multistrain, high-resolution haplotype map for the 99-Mb mouse Chromosome 16 using ∼70,000 single nucleotide polymorphism (SNP) markers derived from whole-genome shotgun sequencing of five laboratory inbred strains. We discovered that large polymorphic blocks (i.e., regions where only two haplotypes, thus one SNP conformation, are found in the five strains), large monomorphic blocks (i.e., regions where the five strains share the same haplotype), and fragmented blocks (i.e., regions of greater complexity not resembling at all the first two categories) span 50%, 18%, and 32% of the chromosome, respectively. The haplotype map has 98% accuracy in predicting mouse genotypes in two other studies. Its predictions are also confirmed by experimental results obtained from resequencing of 40-kb genomic sequences at 21 distinct genomic loci in 13 laboratory inbred strains and 12 wild-derived strains. We demonstrate that historic recombination, intra-subspecies variations and inter-subspecies variations have all contributed to the formation of the three distinctive genetic signatures. The results suggest that the controlled complexity of the laboratory inbred strains may provide a means for uncovering the biological factors that have shaped genetic variation patterns.
- 1 February 2005
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 15 (2) , 241-249
Open AccessA high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns
Understanding of the structure and the origin of genetic variation patterns in the laboratory inbred mouse provides insight into the utility of the mouse model for studying human complex diseases and strategies for disease gene mapping. In order to address this issue, we have constructed a multistrain, high-resolution haplotype map for the 99-Mb mouse Chromosome 16 using ∼70,000 single nucleotide polymorphism (SNP) markers derived from whole-genome shotgun sequencing of five laboratory inbred strains. We discovered that large polymorphic blocks (i.e., regions where only two haplotypes, thus one SNP conformation, are found in the five strains), large monomorphic blocks (i.e., regions where the five strains share the same haplotype), and fragmented blocks (i.e., regions of greater complexity not resembling at all the first two categories) span 50%, 18%, and 32% of the chromosome, respectively. The haplotype map has 98% accuracy in predicting mouse genotypes in two other studies. Its predictions are also confirmed by experimental results obtained from resequencing of 40-kb genomic sequences at 21 distinct genomic loci in 13 laboratory inbred strains and 12 wild-derived strains. We demonstrate that historic recombination, intra-subspecies variations and inter-subspecies variations have all contributed to the formation of the three distinctive genetic signatures. The results suggest that the controlled complexity of the laboratory inbred strains may provide a means for uncovering the biological factors that have shaped genetic variation patterns.
- Open Access
- 1 November 2003
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 73 (5) , 1073-1081
Genomewide Distribution of High-Frequency, Completely Mismatching SNP Haplotype Pairs Observed To Be Common across Human Populations
- 1 November 2003
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 73 (5) , 1073-1081
Open AccessGenomewide Distribution of High-Frequency, Completely Mismatching SNP Haplotype Pairs Observed To Be Common across Human Populations